Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.

http://www.bmj.com/content/352/bmj.i610

We hope to be able to offer the full text article on Medicine Matters diabetes in the near future.